Macrophage colony stimulating-factor transcripts are differentially regulated in rat bone-marrow by gender hormones

Endocrinology

Volumn 140, Issue 1, 1999, Pages 273-279

  Lea, C K ^a   Sarma, U ^a   Flanagan, Adrienne M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ANTIANDROGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; ESTRADIOL; ESTROGEN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; BONE TUMOR; CONTROLLED STUDY; FEMALE; GENDER; GENE EXPRESSION; HORMONAL REGULATION; NONHUMAN; OSTEOCLAST; OVARIECTOMY; PRIORITY JOURNAL; RAT; SKELETON;

EID: 0032950625     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.1.6451     Document Type: Article

References (53)

1. 1. Turner RT, Riggs BL, Spelsberg TC 1994 Skeletal effects of estrogen. Endocr Rev 15:275-300
2. 2. Wronski TJ, Cintron M, Doherty AL, Dann LM 1988 Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681-686
3. 3. Wronski TJ, Cintron M, Dann LM 1988 Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 43:179-183
4. 4. Raisz LG, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M, Shoukri K, Smith J 1996 Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 81:37-43
5. 5. Lea CK, Flanagan AM 1998 Physiological plasma levels of androgens reduce bone loss in the ovariectomized rat. Am J Physiol 274:E328-E335
6. 6. Lea CK, Moxham V, Reed MJ, Flanagan AM 1998 Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogens. J Endocrinol 156:331-339
7. 7. Kitazawa R, Kimble R, Vannice JL, Kung VT, Pacifici R 1994 Interleukin 1-receptor antagonist and tumor necrosis binding protein decrease osteoclast formation and bone resorption in ovariectomised rats. J Clin Invest 94:2397-2406
8. 8. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R 1995 Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136:3054-3061
9. 9. Rifas L, Kenney JS, Marcelli M, Pacifici R, Cheng SL, Daeson LL, Avioli LV 1995 Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumour necrosis factor-alpha is not regulated by ovarian steroids. Endocrinology 136:4056-4067
10. 10. Ammann P, Rizzoli R, Bonjour J-P, Bourrin S, Meyer J-M, Vassalli P, Garcia I 1997 Transgenic mice expressing soluble tumour necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 99:1699-1703
11. 11. Kimble RB, Bain S, Pacifici R 1997 The functional block of TNF but not IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12:935-941
12. 12. Lorenzo J, Naprta A, Rao Y, Alander C, Glaccum M, Widmer M, Gronowicz J, Kalinowski J, Pilbeam C 1998 Mice lacking the type 1 interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinology 139:3022-3025
13. 13. Kawaguchi H, Pilbeam CC, Vargas SJ, Morse EE, Lorenzo JA, Raisz LG 1995 Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae. J Clin Invest 96:539-548
14. 14. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin 6. Science 257:88-91
15. 15. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC 1992 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891
16. 16. Passeri G, Girasole G, Jilka RL, Manolagas SC 1993 Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 133:822-828
17. 17. Miyaura A, Kusano K, Masuzawa T, Chaki O, Onoe Y, Aoyagi M, Sasaki T, Tamura T, Koishihara Y, Ohsugi Y, Suda T 1995 Endogenous bone resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J Bone Miner Res 10:1365-1373
18. 18. Most W, Schot L, Edervees A, van der WeepPals L, Papapoulos S, Lowik C 1995 In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through and effect on osteoclastogenesis. J Bone Miner Res 10:1523-1530
19. 19. Finkelman RD, Bell NH, Strong DD, Demers LM, Baylink DJ 1992 Ovariectomy selectively reduces the concentration of transforming growth factor β in rat bone: implications for estrogen deficiency-associated bone loss. Proc Natl Acad Sci USA 89:12190-12193
20. 20. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF 1996 Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med 2:1132-1136
21. 21. Kimble RB, Srivastava S, Ross FP, Matayoshi A, Pacifici R 1996 Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1-and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem 271:28890-28897
22. 22. Sarma U, Edwards M, Motoyoshi K, Flanagan AM 1998 17β-Estradiol inhibits human osteoclast formation in vitro. J Cell Physiol 175:99-108
23. 23. Van Bezooijen RL, Farih-Sips HCM, Papapoulos SE, Lowick CWGM 1998 IL-1α, IL-1β, IL-6, and TNF-α steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice. J Bone Miner Res 13:185-194
24. 24. Vargas SJ, Naprta A, Lee S-K, Kalinowski H, Kawaguchi H, Pilbeam CC, Raisz LG, Lorenzo JA 1996 Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone-marrow, and marrow stromal cell cultures after ovariectomy. J Bone Miner Res 11:1926-1934
25. 25. Felix R, Cecchini MG, Fleisch H 1990 Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127:2592-2594
26. 26. Wiktor-Jedrzejczak W, Bartocci A, Ferrante Jr AW, Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER 1990 Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 87:4828-4832
27. 27. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Isogai Y, Suda T 1991 Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells. Endocrinology 128:1792-1796
28. 28. Yao G-Q, Sun B-h, Hammond EE, Spencer EN, Horowitz MC, Insogna KL, Weir EC 1998 The cell-surface form of colony-stimulating factor-1 is regulated by osteotropic agents and supports formation of multinucleated osteoclast-like cells. J Biol Chem 273:4119-4128
29. 29. Lea CK, Ebrahim H, Tennent S, Flanagan AM 1997 Aromatase cytochrome transcripts are detected in fractured human bone but not in normal skeletal tissue. Bone 21:433-440
30. 30. Yoshida H, Hayashi S-I, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S-I 1990 The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442-444
31. 31. Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, Abe M, Kumegawa M, Suda T 1991 Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 173:269-272
32. 32. Sarma U, Flanagan AM 1996 Macrophage-colony stimulating factor (M-CSF) induces substantial osteoclast formation in human bone-marrow cultures. Blood 88:2531-2540
33. 33. Fujikawa Y, Quinn JMW, Sabokbar A, McGee JOD, Athanasou NA 1996 The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137:4058-4060
34. 2, interleukin 1α and tumor necrosis factor α increase human osteoclast formation and bone resorption in vitro. Endocrinology 139:3157-3164
35. 35. Rajavashisth TB, Eng R, Shadduck RK, Waheed A, Ben-Avram CM, Shively JE, Lusis AJ 1987 Cloning and tissue-specific expression of mouse macrophage colony-stimulating factor mRNA. Proc Natl Acad Sci USA 84:1157-1161
36. 36. Hattersley G, Owens J, Flanagan AM, Chambers TJ 1991 Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro. Biochem Biophys Res Commun 177:526-531
37. 37. Sundquist KT, Cecchini MG, Marks SC 1995 Colony-stimulating factor-1 injections improve but do not cure skeletal sclerosis in the osteopetrotic (op) mouse. Bone 16:39-46
38. 38. Christiansen C, Christiansen MS, Larsen N-E, Transbol I 1982 Pathophysiological mechanism of estrogen effect on bone metabolism: dose-response relationship in early postmenopausal women. J Clin Endocrinol Metab 55:1124-1130
39. 39. Temeles DS, McGrath HE, Kittler ELW, Shadduck RK, Kister VK, Crittenden RB, Turner B, Quesenberry PJ 1993 Cytokine expression from bone marrow derived macrophages. Exp Hematol 21:388-393
40. 40. Jilka RL, Girasole G, Cooper S, Abrams J, Broxmeyer H 1995 Estrogen loss upregulates hematopoiesis in the mouse: a mediating role of IL-6. Exp Hematol 23:500-506
41. 41. Erben RG, Raith S, Eberle J, Stangassinger M 1998 Ovariectomy augments B lymphopoiesis and generation of monocyte-macrophage precursors in rat bone marrow. Am J Physiol 274:E476-E483
42. 42. Rubin J, Biskobing DM, Jadhav L, Fan D, Nanes MS, Perkins S, Fan X 1998 Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells. Endocrinology 139:1006-1012
43. 43. Takahashi N, Udagawa N, Tanaka S, Murakami H, Owan I, Tamura T, Suda T 1994 Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes. Dev Biol 163:212-221
44. 44. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T 1990 Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 87:7260-7264
45. 45. Kerby JA, Hattersley G, Collins DA, Chambers TJ 1992 Derivation of osteoclasts from hematopoietic colony-forming cells in culture. J Bone Miner Res 7:353-362
46. 46. Massey H, Rae A, Horton MA, Flanagan AM 1998 Characterisation of the human osteoclast phenotype. J Bone Miner Res 13:526
47. 47. Pacifici R 1996 Estrogen, cytokines and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043-1051
48. 48. Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling. New Engl J Med 332:305-311
49. 49. Stanley ER 1994 The Cytokine Handbook, 2nd ed. Academic Press, Harcourt Brace & Company, London, pp 387-418
50. 50. Qiao J-H, Tripathi J, Mishra NK, Cai Y, Tripathi S, Wang X-P, Imes S, Fishbein MC, Clinton SK, Libby P, Lusis AJ, Rajavashisth TB 1997 Role of macrophage colony-stimulating factor in atherosclerosis. Am J Pathol 150:1687-1699
51. 51. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M 1995 Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA 92:8264-8268
52. 52. Flanagan AM, Lader CS 1998 Update on the biological effects of macrophage colony-stimulating factor. Curr Opin Hematol 5:181-185
53. 53. Hayes-Donnelly L, Bree MP, Hunter SE, Keith JC, Schaub RG 1997 Immunoreactive macrophage colony-stimulating factor is increased in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits after recombinant human macrophage colony-stimulating factor therapy. Mol Reprod Dev 46: 92-95